Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:35 PM
NCT ID:
NCT04428151
Group ID:
EG005
Title:
Lenvatinib Switched Over to Pembrolizumab+Lenvatinib
Description:
Participants who experienced centrally verified progressive disease (PD) on lenvatinib monotherapy switched over with Sponsor consultation and received a combination of lenvatinib (once daily 20 mg oral dose) plus pembrolizumab (200 mg 30-minute IV infusion on Day 1 of each 21-day cycle for up to 35 cycles) until a protocol-specified discontinuation criterion was met.
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
18
Other Number Affected:
15
Other Number At Risk:
18
Study:
NCT04428151
Results Section:
NCT04428151
Adverse Events Module:
NCT04428151